BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 10627515)

  • 1. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1.
    Zhang L; Pagano JS
    J Virol; 2000 Feb; 74(3):1061-8. PubMed ID: 10627515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency.
    Zhang L; Pagano JS
    Mol Cell Biol; 1999 Apr; 19(4):3216-23. PubMed ID: 10082588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency.
    Zhang L; Pagano JS
    Mol Cell Biol; 1997 Oct; 17(10):5748-57. PubMed ID: 9315633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma.
    Nonkwelo C; Ruf IK; Sample J
    J Virol; 1997 Sep; 71(9):6887-97. PubMed ID: 9261415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency.
    Schaefer BC; Paulson E; Strominger JL; Speck SH
    Mol Cell Biol; 1997 Feb; 17(2):873-86. PubMed ID: 9001242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
    J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
    Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon regulatory factor 7: a key cellular mediator of LMP-1 in EBV latency and transformation.
    Zhang L; Pagano JS
    Semin Cancer Biol; 2001 Dec; 11(6):445-53. PubMed ID: 11669606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection.
    Yoshioka M; Kikuta H; Ishiguro N; Ma X; Kobayashi K
    J Gen Virol; 2003 May; 84(Pt 5):1133-1140. PubMed ID: 12692278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
    Kis LL; Takahara M; Nagy N; Klein G; Klein E
    Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of Epstein-Barr virus EBNA-1 gene transcription by pRb during restricted latency.
    Ruf IK; Sample J
    J Virol; 1999 Oct; 73(10):7943-51. PubMed ID: 10482541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing.
    Yoshioka M; Crum MM; Sample JT
    J Virol; 2008 Feb; 82(4):1679-87. PubMed ID: 18077719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The latent membrane protein 1 of Epstein-Barr virus (EBV) primes EBV latency cells for type I interferon production.
    Xu D; Brumm K; Zhang L
    J Biol Chem; 2006 Apr; 281(14):9163-9. PubMed ID: 16469740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.
    Bakos A; Banati F; Koroknai A; Takacs M; Salamon D; Minarovits-Kormuta S; Schwarzmann F; Wolf H; Niller HH; Minarovits J
    Virus Genes; 2007 Oct; 35(2):195-202. PubMed ID: 17510783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit.
    Ning S; Hahn AM; Huye LE; Pagano JS
    J Virol; 2003 Sep; 77(17):9359-68. PubMed ID: 12915551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of Epstein-Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain.
    Trivedi P; Spinsanti P; Cuomo L; Volpe M; Takada K; Frati L; Faggioni A
    J Virol; 2001 May; 75(10):4929-35. PubMed ID: 11312367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells.
    Paulson EJ; Fingeroth JD; Yates JL; Speck SH
    Virology; 2002 Jul; 299(1):109-21. PubMed ID: 12167346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
    Sugiura M; Imai S; Tokunaga M; Koizumi S; Uchizawa M; Okamoto K; Osato T
    Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.
    Davenport MG; Pagano JS
    J Virol; 1999 Apr; 73(4):3154-61. PubMed ID: 10074167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1.
    Hahn AM; Huye LE; Ning S; Webster-Cyriaque J; Pagano JS
    J Virol; 2005 Aug; 79(15):10040-52. PubMed ID: 16014964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.